Jerusalem-based OurCrowd announced today that it would lead a $ 12 million investment in the newly formed startup MigVax, an affiliate of The Migal Galilee Research Institute.
Read more here.
The post [MigVax and OurCrowd in Forbes] New Developments In Producing A COVID-19 Vaccine And Identifying High-Risk Individuals appeared first on OurCrowd.
OurCrowd
(Visited 1 times, 1 visits today)